Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Strategies We are Using to Use Up-to Date Clinical Breakpoints for Antimicrobial Susceptibility Testing

ASM-CMO 2025

America Society for Microbiology - Clin Micro Open

Savannah, GA, Jan 29-31, 2025

Oral presentation: Strategies We are Using to Use Up-to Date Clinical Breakpoints for Antimicrobial Susceptibility Testing

Authors: Uprety P

Specialty: Infectious disease

Related content

Publication
Regional Variation in Urinary Escherichia coli Resistance Among Outpatients in Washington State, 2013-2019
Publication
Outpatient Antibiotic Resistance Patterns of Escherichia coli Urinary Isolates Differ by Specialty Type
Publication
Antimicrobial Resistance Patterns of Urinary Escherichia coli Among Outpatients in Washington State 2013 2017 Associations with Age and Sex
Publication
Cluster of Extensively Drug-Resistant Shigella sonnei Carrying blaCTX-M-15 in Los Angeles, California, 2023 to 2024.
Conference Presentation
Next-Generation Sequencing to Detect Drug-Resistant Cytomegalovirus Mutations
Test FAQ
Culture, Blood with Reflex

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.